Serif Levent, Chalikias George, Didagelos Matthaios, Stakos Dimitrios, Kikas Petros, Thomaidis Adina, Lantzouraki Asimina, Ziakas Antonios, Tziakas Dimitrios
Department of Cardiology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
First Cardiology Department, AHEPA General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Cardiorenal Med. 2020;10(3):162-174. doi: 10.1159/000506379. Epub 2020 Apr 14.
Contrast-induced acute kidney injury (CI-AKI) is a frequent complication of percutaneous coronary interventions (PCI). Various groups have developed and validated risk scores for CI-AKI. Although the majority of these risk scores achieve an adequate accuracy, their usability in clinical practice is limited and greatly debated.
With the present study, we aimed to prospectively assess the diagnostic performance of recently published CI-AKI risk scores (up to 2018) in a cohort of patients undergoing PCI.
We enrolled 1,247 consecutive patients (80% men, mean age 62 ± 10 years) treated with elective or urgent PCI. For each patient, we calculated the individual CI-AKI risk score based on 17 different risk models. CI-AKI was defined as an increase of ≥25% (liberal) or ≥0.5 mg/dL (strict) in pre-PCI serum creatinine 48 h after PCI.
CI-AKI definition and, therefore, CI-AKI incidence have a significant impact on risk model performance (median negative predictive value increased from 85 to 99%; median c-statistic increased from 0.516 to 0.603 using more strict definition criteria). All of the 17 published models were characterized by a weak-to-moderate discriminating ability mainly based on the identification of "true-negative" cases (median positive predictive value 19% with liberal criterion and 3% with strict criterion). In none of the models, c-statistic was >0.800 with either CI-AKI definition. Novel, different combinations of the >35 independent variables used in the published models either by down- or by up-scaling did not result in significant improvement in predictive performance.
The predictive ability of all models was similar and only modest, derived mainly by identifying true-negative cases. A new approach is probably needed by adding novel markers or periprocedural characteristics.
造影剂诱导的急性肾损伤(CI-AKI)是经皮冠状动脉介入治疗(PCI)常见的并发症。多个研究团队已开发并验证了CI-AKI的风险评分。尽管这些风险评分大多具有足够的准确性,但其在临床实践中的实用性有限且备受争议。
在本研究中,我们旨在前瞻性评估最近发表的CI-AKI风险评分(截至2018年)在接受PCI治疗的患者队列中的诊断性能。
我们纳入了1247例连续接受择期或急诊PCI治疗的患者(80%为男性,平均年龄62±10岁)。对于每位患者,我们根据17种不同的风险模型计算个体CI-AKI风险评分。CI-AKI定义为PCI术后48小时内PCI前血清肌酐升高≥25%(宽松标准)或≥0.5mg/dL(严格标准)。
CI-AKI的定义以及CI-AKI的发生率对风险模型的性能有显著影响(中位阴性预测值从85%增加到99%;使用更严格的定义标准时,中位c统计量从0.516增加到0.603)。所有17个已发表的模型均具有弱至中等的区分能力,主要基于对“真阴性”病例的识别(宽松标准下中位阳性预测值为19%,严格标准下为3%)。在任何模型中,无论采用哪种CI-AKI定义,c统计量均未>0.800。已发表模型中使用的35个以上独立变量通过向下或向上缩放得到的新的不同组合,在预测性能上均未显著改善。
所有模型的预测能力相似且仅为中等,主要通过识别真阴性病例得出。可能需要一种新的方法,增加新的标志物或围手术期特征。